- Global self-injection device market to Clock CAGR of 13.4% during 2018 – 2026, versatile use of pen injectors for management of chronic disorders
- Technological advancements in wearable injectors and auto injectors to benefit home care, both expected to be lucrative segments
ALBANY, N.Y., April 1, 2021 /PRNewswire/ -- Self-injection devices have become a mainstay of numerous infusion therapies for long-term management of chronic conditions, mainly by making subcutaneous delivery of medicines and hormones easier. This is the key drive for the evolution in the self injection devices market. Advances in design and engineering of self-injection devices are reinforcing uptake in patient populations in homecare settings, notably for rheumatoid arthritis and diabetes. A number of choices among target patients in the use of these self-injection devices in chronic inflammatory diseases are propelling strides in the market. Among various technologies, pen injectors have caught on marked momentum, due to their being inexpensive and the aspect that they are easy to use. Auto injectors and wearable injectors are highly lucrative segments. The later segment is projected to clock CAGR of 20.0% from 2018 to 2026.
The global market is projected to reach valuation of US$ 11,380.9 Mn by 2026, clocking CAGR of 13.4% during the forecast period of 2018 – 2026.
Key Findings of Self-injection Device Market Study
Need for long-term management of chronic conditions boosts uptake
The growing morbidity and mortality of chronic diseases is a key aspect spurring the market proposition of self-injection devices. For instance, diabetes was considered as the seventh leading cause of death in 2016, per the WHO. Per a fact sheet by the CDC, the premature mortality rate of diabetes in high-income countries increased during 2010-2016. In low- and middle-income countries, the prevalence of diabetes is higher. Thus, the large presence of target populations has kept the self-injection device market brimming with opportunities. Self-injection devices make access to insulin therapy affordable and the administration easy in home care. Additionally, they reduce the caregiver burden. In rheumatology, biologic self-injection devices have grown in acceptance due to the potential of long-term disease control. In general, the use of biosimilar drugs is gaining acceptance in infusion therapy.
Advances in Design and Engineering Aid Patients' Comfort
Growing involvement of patients' feedback in the design of self-infusion therapies has enabled manufacturers to make continuous advancements in engineering and design in self-injection device market. Thus, the market has seen some remarkable advancements of self-injection devices, such as pen injectors and wearable drug delivery systems. The safety and reliability have thus increased substantially, benefitting the patient population. This is crucial for elderly patients who may be burdened with lack of dexterity for adequate administration in self-injection devices. For them, advanced actuator technologies have increased the ease of injection.
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."